Capecitabine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Capecitabine and local guidelines before prescribing.

Oral fluoropyrimidine prodrug (chemotherapy)

Mechanism

Oral prodrug of fluorouracil activated preferentially in tumour tissue.

Uses

Colorectal, breast and gastric cancer.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hand-foot syndrome, diarrhoea, mucositis, nausea, myelosuppression, cardiotoxicity.

Interactions

Warfarin interaction with major INR rise; phenytoin levels rise; folinic acid increases toxicity.

Contraindications and cautions

DPD deficiency, severe renal impairment, concurrent warfarin

Monitoring

FBC, LFT, renal function, hand-foot skin toxicity

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Avoid if CrCl below 30

Overdose and reversal

Uridine triacetate for early severe toxicity

Special advice

Check DPD deficiency risk; monitor INR with warfarin; stop for severe diarrhoea or hand-foot reactions.

More from the textbook: uses, cautions and other points
Where it is discussed in the book